Literature DB >> 3860106

The effects of aniracetam (Ro 13-5057) on the enhancement and protection of memory.

G Vincent, A Verderese, E Gamzu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3860106     DOI： 10.1111/j.1749-6632.1985.tb37620.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers.

Authors:  G L Wenk
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.

Authors:  Stefano Marenco; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders.

Authors:  C R Lee; P Benfield
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

4.  Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.

Authors:  I Ito; S Tanabe; A Kohda; H Sugiyama
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

5.  Aniracetam does not improve working memory in neurologically healthy pigeons.

Authors:  Hannah Phillips; Arlene McDowell; Birgitte S Mielby; Ian G Tucker; Michael Colombo
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.